Falsaperla Raffaele, Zanai Rosanna, Collotta Ausilia Desiree, Sortino Vincenzo, Vitaliti Giovanna, Cimino Carla, Scalia Bruna, Vaccalluzzo Marco Simone, Spatuzza Michela, Privitera Grete Francesca, Pulvirenti Alfredo, Pavone Piero, Ruggieri Martino, Marino Andrea, Agati Salvatore
Neonatal Intensive Care Unit, Azienda Ospedaliero Universitaria Policlinico "G. Rodolico-San Marco", San Marco Hospital, University of Catania, 95121 Catania, Italy.
Cardiovascular Department, Mediterranean Pediatric Cardiology Center, Bambino Gesù Children's Hospital, 98035 Taormina, Italy.
Children (Basel). 2024 Nov 26;11(12):1441. doi: 10.3390/children11121441.
Extracorporeal membrane oxygenation (ECMO) is a life support in newborns with severe respiratory failure. Our main objective was to evaluate the mortality of patients and define positive and negative predictive factors of survival.
We performed a Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-conformed retrospective observational study and a systematic review, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Our data were analyzed using R (v.4.2.1). We performed survival analysis, correlation analysis, and Fisher's exact test. The first endpoint was the mortality rate. The second endpoint was to evaluate all factors associated with survival. The third endpoint was focused on complications of ECMO.
Our study included 8 patients treated in our centers and 45 patients from the literature review. Survival was 79%. Positive predictive factors of survival were a length of ECMO of less than 10 days and male neonates, while prematurity and the presence of 2 complications were negative predictive factors.
ECMO functions as life support, although mortality and morbidity risks are high.
体外膜肺氧合(ECMO)是严重呼吸衰竭新生儿的一种生命支持手段。我们的主要目的是评估患者的死亡率,并确定生存的阳性和阴性预测因素。
我们按照流行病学观察性研究报告强化(STROBE)规范进行了一项回顾性观察性研究,并根据系统评价和Meta分析的首选报告项目(PRISMA)进行了系统评价。我们使用R(v.4.2.1)分析数据。我们进行了生存分析、相关性分析和Fisher精确检验。第一个终点是死亡率。第二个终点是评估与生存相关的所有因素。第三个终点聚焦于ECMO的并发症。
我们的研究纳入了在我们中心接受治疗的8例患者以及文献综述中的45例患者。生存率为79%。生存的阳性预测因素是ECMO时长小于10天以及男性新生儿,而早产和存在2种并发症是阴性预测因素。
尽管死亡率和发病风险较高,但ECMO起到了生命支持的作用。